Navigation Links
Singapore First in Southeast Asia to Use Novel Treatment for Sports and Musculoskeletal Injuries
Date:4/14/2009

Originally employed in dentistry, this method of accelerated tissue healing is showing its worth in soft-tissue repair, says one Singapore doctor.

Singapore (PRWEB) April 14, 2009 -- It was first used by dental surgeons about 15 years ago to enhance wound healing of bone grafts during dental reconstructive surgery. Platelet Rich Plasma (PRP) therapy is today being applied in Singapore as an alternative to the conventional mode of treating a wide variety of sports injuries and degenerative conditions in muscles, tendons and joints. The results augur well for professional and weekend sportspersons alike.

"With conventional treatment, a calf muscle tear for instance, would normally take about six weeks to heal. However, with PRP, it would only take half the time. In fact, ultrasonic evidence of healing was apparent as early as seven to 10 days after the injection was administered. Normally, this would have taken between two to three weeks," revealed Dr Patrick Goh, Consultant Sports Physician at SportsMed Central, a clinic that runs under the Healthway Medical Group umbrella.

When injury occurs to musculoskeletal tissues, the body's healing mechanism triggers a blood clot where platelets accumulate. Central to the body's normal healing process, the platelets then release growth factors and signalling molecules (cytokines) to initiate repair. These growth factors attract stem cells to the injured area, stimulate DNA an
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. SingaporeMedicine Highlights Singapore's Advanced Pain Management Techniques
2. Singapore Gives New Sight to the Blind
3. Singapore Premier Women's Hospital Offers Contactless Surgery for Uterine Fibroids
4. Singapore Offers Grants to Research Scientists to Start Labs Here
5. Abbott Opens New Pediatric Nutrition Manufacturing Facility in Singapore
6. Hospital Build Asia Exhibition and Congress 2009: Regions Most Comprehensive Healthcare Infrastructure Planning and Development Event to Debut in Singapore
7. Nanyang Technological University launches first-ever sports degree in Singapore
8. Abbott Opens New Pharmaceutical Research Laboratory in Singapore
9. Abbott Nutrition Announces Voluntary Recall of ZonePerfect(R) Chocolate Peanut Butter Bars, ZonePerfect(R) Peanut Toffee Bars and NutriPals(TM) Peanut Butter Chocolate Bars in U.S., Mexico, New Zealand and Singapore
10. STEMCELL Technologies Launches Direct Distribution to Singapore
11. Singapore is First in Asia to Use Limb-lengthening Technology for Those Wanting to be Taller
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Singapore First in Southeast Asia to Use Novel Treatment for Sports and Musculoskeletal Injuries
(Date:5/23/2013)... drug about to be tested in a clinical trial ... treatment for Alzheimer,s disease has failed to work with ... patients, according to results of a study by University ... of neuroscience affiliated with the Evelyn F. and William ... emphasized the importance of verifying promising research results before ...
(Date:5/23/2013)... 2013 The Rottenstein Law Group LLP, ... created the Tylenol Lawsuit Information Center at http://www.rotlaw.com/tylenol ... and those who are considering filing lawsuits. , ... cause severe liver damage, according to a 2009 report ... the “safety communication,” the FDA warned consumers against using ...
(Date:5/23/2013)... United States Vice President Dick Cheney served as the ... , In front of 1,500 guests yesterday at ... "I am delighted to be here to have the ... Year Award. I think it's a tremendous recognition; I ... company like this because there are obviously a great ...
(Date:5/23/2013)... Click here to read the full article: ... seeing their success develop through merger and acquisition ... to new research carried out by MaRS , the ... compiled its research into a series of articles and ... have shown the general trend that the success of ...
(Date:5/23/2013)... York (PRWEB) May 23, 2013 Parker ... the rights of victims injured by defective medical devices ... Counsel Matthew J. McCauley has been appointed Co-Lead Counsel ... Mirena IUD Products Liability Litigation (Case 7:13-md-02434-CS). The Order, ... and Liaison Counsel are to submit their proposal for ...
Breaking Medicine News(10 mins):Health News:Anti-cancer drug viewed as possible Alzheimer's treatment doesn't work in UF study 2Health News:Anti-cancer drug viewed as possible Alzheimer's treatment doesn't work in UF study 3Health News:Rottenstein Law Group LLP Now Accepting Tylenol Cases, Announces New Tylenol Lawsuit Information Center 2Health News:Acadian Ambulance Honors Paramedic of the Year at Annual Luncheon 2Health News:Merrill DataSite Releases New Comments: Trends amidst Canadian and US Tech M&A 2Health News:Merrill DataSite Releases New Comments: Trends amidst Canadian and US Tech M&A 3Health News:Merrill DataSite Releases New Comments: Trends amidst Canadian and US Tech M&A 4Health News:U.S. District Court Appoints Parker Waichman LLP’s Matthew J. McCauley to Leadership Role in Mirena IUD Litigation 2
... , LOS ANGELES, Dec. 1 Gooooooaaaaaal! ... 2009/2010 growing season with a fresh starting lineup that expands ... an award-winning soccer player, coach and mom - will captain ... sidelines and online. Combined with league sponsorship expansion into Texas ...
... 2009 issue of the Journal of Thoracic Oncology ... metastatic lung cancer has improved over the last two decades ... an analysis of over 100,000 patients with stage IV non-small ... evaluate trends in survival between 1990 and 2005 to assess ...
... , LONDON, Dec. 1 ... devices market, particularly in the wireless assisted living devices segment. This ... this growth is rising awareness levels among an ageing population about ... elderly prefer to age at home - a trend supported by ...
... ... families prepare for and embrace caring for loved ones , ... Cincinnati, Ohio (PRWEB) December 2, 2009 -- Charles Puchta is ... , , ,“While we hope our loved ones live long, healthy and prosperous lives, the ...
... ... The American Meditation Institute (AMI) found that daily meditation, diaphragmatic breathing and yoga ... ... NY (PRWEB) December 1, 2009 –– A new retrospective, interview-based, case study found ...
... 1 "The patient will see you now." That is the ... of Minnesota,s 10,000 employees and family members today, becoming the first ... have access to Online Care Anywhere(SM). Online Care Anywhere allows patients ... onto a computer or picking up the phone. Blue Cross is ...
Cached Medicine News:Health News:Olympic Gold Medalist, World Cup Champion and Soccer Hall of Famer Joy Fawcett Sports A New Uniform as an Official Cuties(R) California Mandarin and Clementine Spokes-Mom 2Health News:Olympic Gold Medalist, World Cup Champion and Soccer Hall of Famer Joy Fawcett Sports A New Uniform as an Official Cuties(R) California Mandarin and Clementine Spokes-Mom 3Health News:Olympic Gold Medalist, World Cup Champion and Soccer Hall of Famer Joy Fawcett Sports A New Uniform as an Official Cuties(R) California Mandarin and Clementine Spokes-Mom 4Health News:Ageing Demographic Boosts Uptake of Wireless Patient Monitoring Devices Across Europe, Finds Frost & Sullivan 2Health News:Ageing Demographic Boosts Uptake of Wireless Patient Monitoring Devices Across Europe, Finds Frost & Sullivan 3Health News:Aging Expert's New Book Helps Boomers Address Challenges of Caregiving 2Health News:New American Meditation Institute Study Reports Wide-Ranging Health Benefits from Meditation and Yoga 2Health News:New American Meditation Institute Study Reports Wide-Ranging Health Benefits from Meditation and Yoga 3Health News:Blue Cross and Blue Shield of Minnesota and Fairview Health Services Launch Online Care Anywhere(TM) 2Health News:Blue Cross and Blue Shield of Minnesota and Fairview Health Services Launch Online Care Anywhere(TM) 3
(Date:5/23/2013)... -- BioElectronics Corporation (OTC Pink: BIEL), the maker of very ... panel meeting for non-thermal shortwave diathermy: The ... Meeting was held on May 21, 2013 in ... the meeting was very narrow, in that the FDA ... application of non-thermal shortwave diathermy for the treatment of ...
(Date:5/23/2013)... May 23, 2013 Halozyme Therapeutics, Inc. ... appointment of David A. Ramsay ... most recently Vice President, Corporate Development at Halozyme. ... "With his established financial management experience and ... working in our commercial group for the last ...
(Date:5/23/2013)... CARLSBAD, Calif. , May 23, 2013 Isis ... antisense therapeutics, today announced that management will present a company ... Health Care Conference on Thursday, May 30, 2013 at 8:40 ... A live audio webcast of the presentation will be ... Web site, www.isispharm.com .  A replay will be available ...
Breaking Medicine Technology:BioElectronics and Pulsed Shortwave Therapy Make Progress 2Halozyme Therapeutics Names David A. Ramsay Chief Financial Officer 2Isis Pharmaceuticals to Present at the Deutsche Bank 38th Annual dbAccess Health Care Conference 2
... Resources, one of the world,s leading research and ... that the increased generic erosion of key drugs ... (Abbott/Sanofi-Aventis,s Depakote/Abbott,s Depakote ER, generics), combined with projected ... will cause a precipitous $2.3 billion decline in ...
... Aug. 25 Actelion Pharmaceuticals US, Inc., today ... (FDA) has approved the brand name VELETRI® for the ... available since April 2010 as Epoprostenol for Injection for ... (PAH) and PAH associated with the scleroderma spectrum of ...
Cached Medicine Technology:Through 2019, Increased Generic Erosion of Key Agents Such as Lamictal and Depakote/Depakote ER Will Cause a Precipitous $2.3 Billion Decline in the Bipolar Disorder Drug Market 2Actelion Pharmaceuticals Announces FDA Approval of Brand Name for Commercially Available VELETRI® (epoprostenol for injection) for Pulmonary Arterial Hypertension 2Actelion Pharmaceuticals Announces FDA Approval of Brand Name for Commercially Available VELETRI® (epoprostenol for injection) for Pulmonary Arterial Hypertension 3Actelion Pharmaceuticals Announces FDA Approval of Brand Name for Commercially Available VELETRI® (epoprostenol for injection) for Pulmonary Arterial Hypertension 4
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 7.0 mm and length 8.7 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 10.0 mm and length 10 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 8.0 mm and length 5 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 13.0 mm and length 15 mm....
Medicine Products: